[{"uuid": "9db39748-5457-3150-94f9-6a7da22b0d22", "title": "Stock Market Today: Dow Jones Battles Back As These Bill Ackman Stocks Lag; Palantir Pops, Eyes All-Time High (Live Coverage)", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/9db39748-5457-3150-94f9-6a7da22b0d22/stock-market-today%3A-dow-jones.html", "providerPublishTime": 1738617261, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/SabZEYh7HDO1yigvkZdVxw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f04c3cb3697f6e815894fe5b90cf46bd", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/AQlFxLMyVs50O5V2D2OmRw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f04c3cb3697f6e815894fe5b90cf46bd", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "4b0eca03-c8fe-39d5-8de6-0eea8b4c048d", "title": "This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/4b0eca03-c8fe-39d5-8de6-0eea8b4c048d/this-drug-stock-sits-on-a.html", "providerPublishTime": 1738328430, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/DH3UgkK4QXtgzl8CIpO0pg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/e34bac118700a392fe2687ed0a75e529", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/hEbYMHLhh9IM_8DzmYvmnw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/e34bac118700a392fe2687ed0a75e529", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["TEVA", "TEVJF", "CPRX"]}, {"uuid": "958a2d75-4267-3405-8fbc-7237403ebe39", "title": "Harmony Biosciences Stock Scores 80-Plus RS Rating", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/958a2d75-4267-3405-8fbc-7237403ebe39/harmony-biosciences-stock.html", "providerPublishTime": 1738269120, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/NwWA8TFUop1mTG1lrhrFew--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/62147566276b3a75eab1ea938001a116", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/QnfPA1QvRdFCAXh9aohfdg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/62147566276b3a75eab1ea938001a116", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HRMY", "CPRX"]}, {"uuid": "b503c6b6-5002-30e9-8309-00348915e55a", "title": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/boost-portfolio-top-medical-stocks-140013009.html", "providerPublishTime": 1737986413, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UACuRym2G7Sc_7yqOtSLVQ--~B/aD0yMzUxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0", "width": 3000, "height": 2351, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/4xltbIIZEXRptTswpC4cYw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CPRX", "AMGN"]}, {"uuid": "ac13d4d3-52b7-3e11-8d01-7d7f6a2a4790", "title": "Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/heres-why-catalyst-pharmaceutical-cprx-145016984.html", "providerPublishTime": 1737730216, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/YliGu3uiWo7T6YkWQuaEpA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/7CzRl1qWfIp6OHUqiEloWA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CPRX"]}, {"uuid": "f8cdb4e0-3ab6-35e1-acc8-c1b30b6f7bdb", "title": "Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/catalyst-pharmaceuticals-receives-prestigious-ranking-130300965.html", "providerPublishTime": 1737637380, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/w6J7NUBXwEgAPQ7MeEQYzA--~B/aD05NTt3PTI5MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/e91b4386329f3554477764cfdda06e87", "width": 291, "height": 95, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/4muCx.eZ_aIJTNBQKHi0sg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/e91b4386329f3554477764cfdda06e87", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CPRX"]}, {"uuid": "23332e71-001b-3e25-926f-d8618d80a0b8", "title": "Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/growth-investor-1-stock-could-144509837.html", "providerPublishTime": 1737643509, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/nxwFIPS2ImeTQYZMYlnAgg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209", "width": 900, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/b7m1GSxHeAeYrh4cHL3hRA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CPRX"]}, {"uuid": "38a9e65d-6ab4-3e6c-9835-aa04731a3169", "title": "Catalyst Pharmaceuticals Sub-Licensee DyDo Pharma Launches Firdapse in Japan for Autoimmune Disorder Treatment", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/catalyst-pharmaceuticals-sub-licensee-dydo-180547306.html", "providerPublishTime": 1737482747, "type": "STORY"}, {"uuid": "5bb4664c-9975-3354-94af-63e89dcceb48", "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/why-investors-advantage-2-medical-140009676.html", "providerPublishTime": 1737554409, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UPInF06X6fJkTqeimnpZuQ--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 900, "height": 745, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/tlKVbaKmxwUbiS87UIMwQA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CPRX", "ZTS"]}, {"uuid": "0d378053-2cb3-3f0d-b7dd-d3a37a8369cd", "title": "Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE\u00ae in Japan", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/catalyst-pharmaceuticals-announces-sub-licensee-131900910.html", "providerPublishTime": 1737465540, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/w6J7NUBXwEgAPQ7MeEQYzA--~B/aD05NTt3PTI5MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/e91b4386329f3554477764cfdda06e87", "width": 291, "height": 95, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/4muCx.eZ_aIJTNBQKHi0sg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/e91b4386329f3554477764cfdda06e87", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CPRX"]}, {"uuid": "985b3f12-0f16-35f7-8d78-6664259960a4", "title": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/value-investor-1-stock-could-144006534.html", "providerPublishTime": 1737470406, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/132juehTNIyEUn7pK7.GPA--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619", "width": 900, "height": 506, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/twDpSkUZEyzUBc0qEMHAqw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CPRX"]}, {"uuid": "9b29f90d-c811-39b2-90cb-1e1db0c183f1", "title": "BeiGene Stock Meets 80-Plus RS Rating Benchmark", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/9b29f90d-c811-39b2-90cb-1e1db0c183f1/beigene-stock-meets-80-plus.html", "providerPublishTime": 1736973840, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CV9O53fka7aSG3Lpv1LaCQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/34cca67fae26bc0f236698386833518e", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/VCbf8TE4edJ63Xauo_uFmA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/34cca67fae26bc0f236698386833518e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BEIGF", "ONC", "HALO", "CPRX", "EXEL"]}]